Latest fibrosis Stories

The First Annual Linda Biggs 5K Walk/Run, Quest for Cure is Saturday, October 15th LEXINGTON, S.C., Oct. 11, 2011 /PRNewswire-USNewswire/ -- A S.C. woman is holding a 5K in Lexington to raise awareness of lung disease that claimed her mother-in-law's life just a couple of years ago. Kathy Biggs, a licensed physician therapist, saw her mother-in-law suffer from Pulmonary Fibrosis (PF), a disease that scars the lungs and suffocates its victims. There was nothing even she, a medical...

Agile Sciences will collaborate with Dr. Richard Boucher, Director of the Cystic Fibrosis Center at the University of North Carolina, Chapel Hill Raleigh, NC (PRWEB) October 10, 2011 The National Institutes of Health (NIH) has awarded Agile Sciences a Phase I STTR Grant to evaluate the efficacy of Agile Sciences’ proprietary Agilyte™ anti-biofilm molecules for treating lung infections of cystic fibrosis patients. The molecules will be tested in a new model of chronic lung...

Study points to a phosphorylation pathway that may contribute to the development of lung injury and fibrosis A study by researchers at the University of California, San Diego School of Medicine may lead to a way to prevent the progression, or induce the regression, of lung injury that results from use of the anti-cancer chemotherapy drug Bleomycin. Pulmonary fibrosis caused by this drug, as well as Idiopathic Pulmonary Fibrosis (IPF) from unknown causes, affect nearly five million people...

Meetings Part of National Pulmonary Fibrosis Awareness Week CULVER CITY, Calif., Sept. 28, 2011 /PRNewswire-USNewswire/ -- At 6'1", solid and handsome, Douglas Nance looks more like a football star than a man dying from Pulmonary Fibrosis (PF). Only the oxygen tank he carries and the plastic tubing in his nose gives him away. Nance, 56, and his wife, Martina, walked the halls of Congress just days ago asking for help for the lung disease that is scarring his lungs, and stealing his...

Pulmonary Fibrosis Foundation On Course to Achieve Major 2011 Initiatives CHICAGO, Sept. 21, 2011 /PRNewswire-USNewswire/ -- The Pulmonary Fibrosis Foundation (PFF) is pleased to announce that it has received an official endorsement from the American Thoracic Society (ATS) for its upcoming scientific conference, IPF Summit 2011: From Bench to Bedside, taking place on December 1-3, 2011, in Chicago, Illinois. "We are proud to have an ATS endorsement for the Summit," says Daniel M. Rose,...

RIDGEFIELD, CT, Sept. 21, 2011 /PRNewswire/ -- Boehringer Ingelheim's investigational tyrosine kinase inhibitor (TKI) BIBF 1120 demonstrated a positive trend in reducing lung function decline in patients with idiopathic pulmonary fibrosis (IPF), according to phase II clinical trial results published today online in the New England Journal of Medicine (NEJM). IPF is a progressive and severely debilitating lung disease with a high mortality rate, for which there are no approved treatments in...

Cystic fibrosis (CF), a chronic disease that clogs the lungs and leads to life-threatening lung infections, is caused by a genetic defect in a chloride channel called cystic fibrosis transmembrane conductase regulator (CFTR). Although scientists do not fully understand how or why this defect occurs, a team of researchers at The Hospital for Sick Children (SickKids) in Toronto, Ontario, Canada has found a promising clue: a protein called ubiquitin ligase Nedd4L. In a study led by Daniela...

Ninth Annual National Pulmonary Fibrosis Awareness Week Sept. 18-24 CULVER CITY, Calif., Sept. 19, 2011 /PRNewswire-USNewswire/ -- Doris Lowenthal planned to be on Capitol Hill this week. As a member of the Coalition for Pulmonary Fibrosis' (CPF) Pulmonary Fibrosis (PF) Awareness Week volunteer team, she was scheduled for more than 60 meetings with members of Congress and staff members. She prepared just what she wanted to say to them to gain their compassion and their co-sponsorship of a...

American Thoracic Society and Coalition for Pulmonary Fibrosis Partner to Raise Awareness, Help Patients, Move Legislation on Capitol Hill WASHINGTON, Sept. 12, 2011 /PRNewswire-USNewswire/ -- The American Thoracic Society (ATS) and the Coalition for Pulmonary Fibrosis (CPF) are holding two weeks of national awareness efforts (September 13-18 and Sept. 18-24 respectively) to bring attention to a lethal lung disease that claims as many American lives each year as breast cancer - yet is...

NEW YORK, Sept. 9, 2011 /PRNewswire-USNewswire/ -- At this time of remembrance of the tragedy of 9/11, the Coalition for Pulmonary Fibrosis is reminded of the potentially life-threatening consequences that remain for those who responded to the crisis and worked in its aftermath. Many of them suffer from respiratory ailments, including Pulmonary Fibrosis (PF), and still many more may fall ill in the months and years to come as a result of exposures at the World Trade Center (WTC) site....